5 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow remimazolam: new trials by email Literature Review of remimazolam trials Research Report on remimazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine for Veterans With Parkinson's Disease Ketamine, Remimazolam - Parkinson's Disease | Phase 2 | Recruiting | VA Office of Research and Development | 80 | 2026-03-01 | 2026-04-13 |
| The Impact of Remimazolam Tosilate on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy Remimazolam, Propofol - Remimazolam Besylate, Thoracoscopic Lobectomy | Phase 1 / Phase 2 | Not yet recruiting | Jinqiao Qian | 150 | 2025-08-01 | 2025-07-25 |
| Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty Remimazolam 20 MG Injection [Byfavo], NaCl 0.9% - Remimazolam, Emergence Delirium | Phase 2 | Unknown | University Hospital of Split | 80 | 2024-03-06 | 2024-05-03 |
| Trial Evaluating the Efficacy of Remimazolam in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Byfavo, Midazolam - Midazolam, Remimazolam | Phase 2 | Unknown | Yeungnam University Hospital | 330 | 2024-03-01 | 2024-02-23 |
| Remimazolam Versus Propofol for Painless Abortion Remimazolam, Propofol, Esketamine - Anesthesia, Abortion Early | Phase 2 | Completed | Maternal and Child Health Hospital of Hubei Province | 100 | 2022-08-01 | 2022-12-02 |
| Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures Remimazolam - Pediatric ALL | Phase 2 / Phase 3 | Active not recruiting | Acacia Pharma Ltd | 100 | 2021-11-15 | 2025-07-01 |
| REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study Remimazolam - Acute Respiratory Failure, COVID-19 | Phase 2 | Completed | Nantes University Hospital | 30 | 2020-11-30 | 2021-11-04 |
| Remimazolam Phase II Cardiac Anesthesia Study Remimazolam, Propofol, Sevoflurane - General Anesthesia | Phase 2 | Completed | Paion UK Ltd. | 90 | 2013-08-01 | 2020-01-18 |
| Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy A. CNS 7056, B. CNS 7056, C. CNS 7056 - Sedation | Phase 2 | Completed | Paion UK Ltd. | 162 | 2010-05-01 | 2019-01-08 |
| Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy CNS 7056, Midazolam - Procedural Sedation, Endoscopy | Phase 2 | Completed | Paion UK Ltd. | 100 | 2009-03-01 | 2019-01-08 |
COVID-19 (1) · Depression (1) · Emergence Delirium (1) · Parkinson Disease (1) · Postoperative Cognitive Complications (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Sepsis (1) · Shock (1) · Stroke (1) · Wounds and Injuries (1)
Paion UK Ltd. (3) · Acacia Pharma Ltd (1) · Jinqiao Qian (1) · Maternal and Child Health Hospital of Hubei Province (1) · Nantes University Hospital (1) · University Hospital of Split (1) · VA Office of Research and Development (1) · Yeungnam University Hospital (1)
United States (4) · China (2) · Croatia (1) · Denmark (1) · France (1) · Germany (1) · South Korea (1)
Ellen R Bradley, MD (1) · Jinqiao Qian, doctor (1) · Na Li, MD (1) · Stefan Probst, MD (1)
PMID 25502841, PMID 26363333, PMID 38760702, PMID 40174701, PMID 41892844